ALESSANDRI, Amedea Caterina
 Distribuzione geografica
Continente #
NA - Nord America 567
EU - Europa 298
AS - Asia 110
AF - Africa 3
SA - Sud America 1
Totale 979
Nazione #
US - Stati Uniti d'America 567
UA - Ucraina 76
CN - Cina 68
FI - Finlandia 64
IT - Italia 53
SG - Singapore 32
IE - Irlanda 23
GB - Regno Unito 22
DE - Germania 19
BE - Belgio 14
SE - Svezia 13
RU - Federazione Russa 6
FR - Francia 5
CI - Costa d'Avorio 3
KR - Corea 3
TR - Turchia 3
IR - Iran 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BR - Brasile 1
HK - Hong Kong 1
PL - Polonia 1
RO - Romania 1
Totale 979
Città #
Chandler 72
Ann Arbor 50
Ashburn 46
Fairfield 44
Jacksonville 42
Wilmington 33
Houston 31
Woodbridge 26
Singapore 24
Des Moines 23
Dublin 23
Seattle 22
Medford 16
Nanjing 16
Brussels 14
New York 14
Cambridge 13
Princeton 11
Boardman 10
Tulsa 9
Dearborn 7
Nanchang 7
Beijing 6
Shenyang 6
Changsha 5
San Diego 5
Tianjin 5
Cagliari 4
Milan 4
Palermo 4
Abidjan 3
Genoa 3
Izmir 3
Jinan 3
Kunming 3
Santa Clara 3
Seongnam 3
Altamura 2
Chicago 2
Duncan 2
Haikou 2
Hebei 2
Lanzhou 2
Lawrence 2
Ningbo 2
Nutley 2
Rome 2
San Paolo di Civitate 2
Tappahannock 2
Tehran 2
Central District 1
Chenzhou 1
Columbus 1
Cutrofiano 1
Dubai 1
Frankfurt Am Main 1
Hangzhou 1
Hefei 1
Jiaxing 1
Kiev 1
Kilburn 1
Ludwigshafen am Rhein 1
Mountain View 1
Munich 1
New Bedfont 1
Philadelphia 1
San Mateo 1
Shenzhen 1
São Paulo 1
Taiyuan 1
Taizhou 1
Verona 1
Totale 661
Nome #
Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia. 158
Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis. 153
Retreatment of interferon plus ribavirin unresponsive patients with chronic hepatitis C with peginterferon alfa 2a plus mycofenolatemofetile or peginterferon alfa 2 a plus ribavirin 91
PREVALENZA ED INCIDENZA DELLE EPATITI CRONICHE IN DIFFERENTI POPOLAZIONI DELLA SICILIA OCCIDENTALE 86
Studio sulla frequenza dei genotipi virali e loro risposta terapeutica su un gruppo di soggetti ex drug dipendents con epatite cronica HCV-correlata. 85
Himpact of liver steatosis on the antiviral response in the hepatitis C virus –associated chronic hepatitis. 85
The treatment of chronic hepatitis C: role of ICAM-1 and response to interferon 75
Safety and efficacy of peginterferon alpha 2a plus mycofenolatemofetile and peginterferon alpha 2a plus Ribavirin in unresponsive patients with chronic hepatitis C 72
safety and efficacy of peginterferon (PEG-IFN) alpha 2a plus mycofenolatemoftile and peginterfron alpha 2a plus ribavirin in unresponsive patients with chronic C hepatitis 67
L’esposizione professionale in ambiente sanitario: attuali dati sulla valutazione e prevenzione del rischio 66
Safety and efficacy of Peginterferon (PEG-IFN) alpha 2 a(40 Kda) plus mycofenolatemofetile (MMF) and Peginterferon alpha 2 a plus Ribavirin (RBV) in unresponsive patients with chronic C hepatitis (CHC). 57
Totale 995
Categoria #
all - tutte 3.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.382


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020127 0 0 0 0 0 24 29 8 23 8 22 13
2020/2021127 4 14 8 14 11 4 15 3 17 3 13 21
2021/2022103 2 29 2 11 1 0 5 6 10 14 5 18
2022/2023170 12 22 1 25 27 34 16 17 11 0 4 1
2023/202494 4 13 5 24 2 19 2 4 0 1 8 12
2024/202545 5 10 3 12 5 10 0 0 0 0 0 0
Totale 995